NTRB News and Press, Nutriband Inc. From 05/16/24

2024-05-16 10:00:47 ET More on Health Care Select Sector SPDR XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care Short interest in S&P 500 ...

The Glinka family invested $4.5 million into Nutriband through the Company's April 2024 private placement ORLANDO, FL / ACCESSWIRE / May 16, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, today announced the appointment of Sergei Glink...

2024-05-15 13:19:52 ET More on mid-day movers & stocks. SunPower: Tariffs Will Help, But Still A Lot Of Work Needed SunPower: Major Difficulties For An Unscalable Business Aeries Technology, Inc (AERT) Q3 2024 Earnings Call Transcript SunPower shares cool...

Nutriband (NASDAQ: NTRB) , a pharmaceutical company with a special focus on transdermal technologies, is featured in an upcoming interview on the RedChip Small Stocks, Big Money(TM) show. During the program, which is scheduled to air on Bloomberg TV this Saturday, May 11, at 7 p.m. ET, Gareth She...

ORLANDO, FL / ACCESSWIRE / May 10, 2024 / RedChip Companies will air interviews with Can-Fite BioPharma Ltd. (NYSE American:CANF) and Nutriband Inc. (NASDAQ:NTRB) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, May 11, at 7 p.m. Eastern ...

150+ Americans die every day from synthetic opioid (e.g. fentanyl) overdose Nutriband’s AVERSA(TM) Fentanyl technology is being developed as an innovative solution to abuse and misuse rates in prescription opioid patch medications Nutriband raised $8.4 million in a private placement to...

2024-05-03 11:54:35 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nutriband (NASDAQ: NTRB ) just reported results for the fourth quarter of 2023. Nutriband reported earnings per share of -23 cents. The company reported revenue of $52...

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...

Nutriband (NASDAQ: NTRB, NTRBW) , a pharmaceutical company with a special focus on transdermal technologies, today announced that it has selected IBN , a multifaceted financial news and publishing company for private and public entities, to assist with its corporate communications initiatives. A...

LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Nutriband Inc. (NASDAQ: NTRB) , a pharmaceutical company with a specific focus on transdermal technologies, today announces it has selected IBN , a multifaceted financial news and publishing company for private and publi...